150
Participants
Start Date
February 5, 2019
Primary Completion Date
February 21, 2020
Study Completion Date
February 21, 2020
Vortioxetine
Flexible doses (10-20 mg) of vortioxetine; 10 mg during the first week which may be increased up to 20 mg week 2-8
Office of Dr. Patrick Bourgoin (FR0011), Angoulême
Cabinet Psyche (FR0012), Douai
Centre Medical Ambroise Pare (FR0007), Élancourt
Dr. David Modavi Md, Office Of (FR0001), Toulouse
Private Practice Dr. Paule Khalifa (FR0010), Toulouse
GHS De Nancy - CPN Laxou (FR0006), Vandœuvre-lès-Nancy
Dr Karim Boutayeb MD, Office of (FR0009), Viersat
DSM Giulianova c/o ospedale di Giulianova (IT0004), Giulianova
Dipartimento Salute Mentale ASL Lecce (IT0006), Lecce
Universita degli Studi di Roma La Sapienza - Azienda Ospedaliera Sant Andrea (IT0013), Rome
JSC Romuvos Klinika (LT0002), Kaunas
Mental Health Centre Kaunas Outpatient Clinic (LT0005), Kaunas
JSC Nefridos klinika (LT0006), Klaipėda
Jsc Silutes Mental Health And Psychotherapy Center (LT0001), Šilutė
Antakalnis Psychiatric Consultation Centre (LT0003), Vilnius
PI Mental Health Center of Zirmunai (LT0004), Vilnius
Hospital Universitario Fundacion Alcorcon (ES0009), Alcorcón
Instituto Internacional de Neurociencias Aplicadas (ES0004), Barcelona
Centro De Salud Mental De Foios (ES0002), Foios
University of Oviedo (ES0011), Oviedo
Francesca Canellas Dols (ES0005), Palma de Mallorca
Hospital Clínico Universiatrio de Salamanca (ES0001), Salamanca
Centro De Especialidades A Doblada (ES0006), Vigo
H. Lundbeck A/S
INDUSTRY